Express Scripts Announces 2017 Third Quarter Results

Go back to Express Scripts Announces 2017 Third Quarter Results

Express Scripts (ESRX) PT Raised to $59 at Baird Following 3Q Report

October 25, 2017 9:11 AM UTC

Baird raised its price target on Express Scripts (NASDAQ: ESRX) to $59.00 (from $57.00) while maintaining a Neutral rating following the company's 3Q. Adjusted EBITDA was flat at $1.95B but missed Street by $17M or 0.9%. Adjusted EPS grew 9% to $1.90 and aligned with Street and guidance... More

Express Scripts (ESRX) Tops Q3 EPS by 3c, Offers Guidance

October 24, 2017 4:04 PM UTC

Express Scripts (NASDAQ: ESRX) reported Q3 EPS of $1.90, $0.03 better than the analyst estimate of $1.87. Revenue for the quarter came in at $24.68 billion versus the consensus estimate of $25.64 billion.

GUIDANCE:

Express Scripts sees FY2017 EPS of $6.97-$7.05, versus the consensus of... More